[Vertigo in adolescents with hemicrania]

Minerva Pediatr. 2001 Oct;53(5):468.
[Article in Italian]
No abstract available

MeSH terms

  • 5-Hydroxytryptophan / administration & dosage
  • 5-Hydroxytryptophan / therapeutic use
  • Adolescent
  • Age Factors
  • Antidepressive Agents / administration & dosage
  • Antidepressive Agents / therapeutic use
  • Female
  • Flunarizine / administration & dosage
  • Flunarizine / therapeutic use
  • Humans
  • Male
  • Migraine Disorders / complications*
  • Migraine Disorders / diagnosis
  • Migraine Disorders / prevention & control
  • Time Factors
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use
  • Vertigo / diagnosis
  • Vertigo / etiology*
  • Vertigo / prevention & control

Substances

  • Antidepressive Agents
  • Vasodilator Agents
  • 5-Hydroxytryptophan
  • Flunarizine